Biological Sciences Division
Published May 21, 2020 | Version v1
Patent Open

METHOD FOR TREATING IDIOPATHIC PULMONARY FIBROSIS

Creators

  • 1. University of Chicago
  • 2. Cornell University

Contributors

Description

Aspects of the disclosure relate to a method for treating idiopathic pulmonary fibrosis (IPF) in a patient with N-acetylcysteine (NAC) comprising administering NAC to a patient after a sample from the patient has been genotyped and determined to be any one of: a) homozygous or heterozygous for a thymine at the single nucleotide polymorphism rs3750920; b) homozygous or heterozygous for guanine at the single nucleotide polymorphism rs5743894; or c) homozygous or heterozygous for thymine at the single nucleotide polymorphism rs35705950.

Files

US20200155494.pdf

Files (1.7 MB)

Name Size Download all
md5:6a04b286349f2f89a19336a9815466d9
1.7 MB Preview Download

Additional details

Identifiers

Patent application number
US 202016744822 A
Patent number
US 2020/0155494 A1
Other
oai:uchicago.tind.io:9490

Dates

Patent filed
2020-01-16

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Medicine